IP Library Granted Patent US 9,327,049
Granted Patent B2
US 9,327,049 · App. 14/374,988 · Granted May 3, 2016

Anti-adhesion polymer composition capable of supporting growth factor

Inventors: Jung Ju Kim (Gyeonggi-Do, KR); Jung Won So (Gyeonggi-Do, KR); Hyun Seung Ryu (Gyeonggi-Do, KR); Jun Hyuk Seo (Gyeonggi-Do, KR)
Assignee: CG Bio Co., Ltd.
A61L24/046A61L24/0015A61L24/043A61L31/041A61L31/16C08L71/02A61B2090/0816A61K47/10A61K47/30A61K47/34A61L2300/252A61L2300/414A61L2400/04A61L2400/06C08L2203/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,327,049
App. No.
14/374,988
Granted
May 3, 2016
Kind
B2
Abstract

The present invention relates to an anti-adhesion polymer composition capable of supporting growth factor, which effectively exhibits anti-adhesion function and, at the same time, has an excellent adhesive property so as to be able to easily and continuously adhere to a wound site, has antibacterial and hemostatic properties, and is composed of an injectable formulation suitable for use in minimally invasive surgery, laparoscopic surgery or the like. The anti-adhesion polymer composition capable of supporting growth factor comprises: 24-50 wt % of a polyethyleneglycol-polypropyleneglycol-polyethyleneglycol (PEG-PPG-PEG) block copolymer having a polyethyleneglycol (PEG) content of 65-85 wt % and a molecular weight of 6,000-20,000 Da; 0.03-5 wt % of gelatin; 0.03-5 wt % of chitosan; and distilled water.

Claims (4)

1. An anti-adhesion polymer composition consisting essentially of: 24-50wt % of a polyethyleneglycol-polypropyleneglycol-polyethyleneglycol (PEG-PPG-PEG) block copolymer having a polyethyleneglycol (PEG) content of 65-85wt % and a molecular weight of 6,000-20,000Da; 0.03-5wt % of gelatin; 0.03-5wt % of chitosan; distilled water; glycerol as a stabilizer for suppressing phase separation of the composition; and at least one growth factor selected from the group consisting of epidermal growth factor (EGF, beta-urogastrone), heparin-binding EGF-like growth factor (HB-EGF), transforming growth factor-α (TGF-α) and fibroblast growth factors (FGFs).

2. The anti-adhesion polymer composition of claim 1 , wherein the block copolymer is composed of two kinds of block copolymers having different weight % of PEG.

3. The anti-adhesion polymer composition of claim 2 , wherein the amount of each of the block copolymers in the composition is 12-25wt %.

4. The anti-adhesion polymer composition of claim 1 , wherein said composition forms an injectable solution which is capable of adhering to a wound site.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2014
From: KIM, JUNG JU; SO, JUNG WON; RYU, HYUN SEUNG; SEO, JUN HYUK
To: CG BIO CO., LTD.
Reel/Frame 033428/0665 →
Priority Claims (1)
KR 10-2012-0020554 · Feb 28, 2012 · national
Continuity (1)
Related Publication 20150010490A1 · Jan 8, 2015